Enterprise Financial Services Corp Ionis Pharmaceuticals Inc Transaction History

Enterprise Financial Services Corp

  • $170 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$33.54 - $40.55 $771 - $932
-23 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$34.54 - $47.25 $414 - $567
12 Added 109.09%
23 $1,000
Q1 2020

May 15, 2020
SELL
$41.6 - $63.4 $3,702 - $5,642
-89 Reduced 89.0%
11 $1,000
Q1 2019

Apr 26, 2019
BUY
$52.92 - $81.17 $5,292 - $8,117
100 New
100 $8,000

Others Institutions Holding IONS

# of Institutions
403
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email